XML 28 R16.htm IDEA: XBRL DOCUMENT
v3.21.2

Warrants and Options | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jul. 31, 2021 | Jan. 31, 2021
Warrants And Options [Abstract] |  |
WARRANTS AND OPTIONS |
| 9. | WARRANTS
The following table summarizes the changes in warrants outstanding and the related price of the shares of the Company’s common stock issued to non-employees of the Company.
|  | Shares |  |  | Exercise Price |  |  | Remaining Life |  |  | Intrinsic Value |
Outstanding, January 31, 2021 |  |  | 141,828 |  |  | $ | 11.99 |  |  |  | 2.16 years |  |  | $ | 285,000 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Expired/Cancelled |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding-period ending July 31, 2021 |  |  | 141,828 |  |  | $ | 11.99 |  |  |  | 1.41 years |  |  | $ | - |
Exercisable - period ending July 31, 2021 |  |  | 141,828 |  |  | $ | 11.99 |  |  |  | 1.41 years |  |  | $ | - |
The following table summarizes additional information relating to the warrants outstanding as of July 31, 2021:
Range of Exercise Prices |  |  | Number Outstanding |  |  | Remaining Contractual Life (Years) |  |  | Exercise Price for Shares Outstanding |  |  | Number Exercisable |  |  | Exercise Price for Shares Exercisable |  |  | Intrinsic Value |
$ | 11.00 |  |  |  | 95,000 |  |  |  | 1.25 |  |  | $ | 11.00 |  |  |  | 95,000 |  |  | $ | 11.00 |  |  | $ | - |
$ | 14.00 |  |  |  | 46,828 |  |  |  | 1.75 |  |  | $ | 14.00 |  |  |  | 46,828 |  |  | $ | 14.00 |  |  | $ | - |
10. | WARRANTS AND OPTIONS
The following table summarizes the changes in warrants outstanding and the related price of the shares of the Company’s common stock issued to non-employees of the Company.
|  |  |  |  | Exercise |  |  | Remaining |  |  | Intrinsic |
|  | Shares |  |  | Price |  |  | Life |  |  | Value |
Outstanding, January 31, 2019 |  |  | 182,500 |  |  | $ | 6.32 |  |  |  | 0.35 |  |  | $ | 4,101,000 |
Granted |  |  | 50,000 |  |  |  | 20.90 |  |  |  | 3.00 years |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Expired/Cancelled |  |  | (162,500 | ) |  |  | 5.38 |  |  |  | - |  |  |  | - |
Outstanding, January 31, 2020 |  |  | 70,000 |  |  | $ | 18.93 |  |  |  | 2.08 years |  |  |  | - |
Granted |  |  | 91,828 |  |  |  | 12.53 |  |  |  | 3.00 years |  |  |  | - |
Expired/Cancelled |  |  | (20,000 | ) |  |  | 14.00 |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding-period ending January 31, 2021 |  |  | 141,828 |  |  | $ | 11.99 |  |  |  | 2.16 |  |  | $ | 853,311 |
Exercisable - period ending January 31, 2021 |  |  | 141,828 |  |  | $ | 11.99 |  |  |  | 2.16 |  |  | $ | 853,311 |
As a result of a completed private placement, the warrants to purchase 50,000 shares at the lesser of (i) $20.90 or, (ii) if the Company completes its public offering of its common stock, 110% of the initial public offering price of the Common Stock in the public offering, became a warrant to purchase 95,000 warrants at $11 per share, subject to adjustment pursuant to the antidilution provisions of the warrant. The Company recorded a derivative liability for the warrants in the amount of $906,678 and reclassed the derivative liability to additional paid-in capital as of January 31, 2021. The following table summarizes additional information relating to the warrants outstanding at January31, 2021:
Range of Exercise Prices |  |  | Number Outstanding |  |  | Remaining Contractual Life(Years) |  |  | Exercise Price for Shares Outstanding |  |  | Number Exercisable |  |  | Exercise Price for Shares Exercisable |
$ | 11.00 |  |  |  | 95,000 |  |  |  | 1.75 |  |  | $ | 11.00 |  |  |  | 95,000 |  |  | $ | 11.00 |
$ | 14.00 |  |  |  | 46,828 |  |  |  | 2.24 |  |  | $ | 14.00 |  |  |  | 46,828 |  |  | $ | 14.00 |
The following table summarizes the changes in options outstanding and the related price of the shares of the Company’s common stock issued to non-employees of the Company.
|  |  |  |  | Exercise |  |  | Remaining |  |  | Intrinsic |
|  | Shares |  |  | Price |  |  | Life |  |  | Value |
Outstanding, January 31, 2019 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | 25,000 |  |  |  | 25.64 |  |  |  | 0.05 years |  |  |  | 232,750 |
Expired |  |  | (25,000 | ) |  |  | 25.64 |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding-period ending January 31, 2020 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Exercisable - period ending January 31, 2020 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |

X
- References No definition available. + Details
Name: | ntrb_WarrantsAndOptionsAbstract
Namespace Prefix: | ntrb_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ntrb_WarrantsAndOptionsTextBlock
Namespace Prefix: | ntrb_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration